Evonik Industries AG (EVKIY)

OTCMKTS · Delayed Price · Currency is USD
9.60
+0.23 (2.45%)
Feb 11, 2026, 12:21 PM EST
Market Cap8.85B -0.3%
Revenue (ttm)16.52B -7.2%
Net Income744.39M +185.6%
EPS1.60 +185.5%
Shares Outn/a
PE Ratio11.89
Forward PE13.17
Dividend0.44 (5.02%)
Ex-Dividend DateMay 30, 2025
Volume400
Average Volume4,817
Open9.50
Previous Close9.37
Day's Range9.50 - 9.60
52-Week Range7.24 - 12.33
Beta0.71
RSI75.74
Earnings DateMar 4, 2026

About Evonik Industries AG

Evonik Industries AG produces and sells specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, and Technology & Infrastructure segments. The Specialty Additives segment offers additives for polyurethane foams; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depr... [Read more]

Sector Materials
Founded 1847
Employees 31,297
Stock Exchange OTCMKTS
Ticker Symbol EVKIY
Full Company Profile

Financial Performance

In 2025, Evonik Industries AG's revenue was 14.07 billion, a decrease of -7.18% compared to the previous year's 15.16 billion. Earnings were 634.00 million, an increase of 185.59%.

Financial numbers in EUR Financial Statements

News

Evonik Industries AG (EVKIY) Q4 2025 Earnings Call Transcript

Evonik Industries AG (EVKIY) Q4 2025 Earnings Call February 4, 2026 7:00 PM ESTCompany ParticipantsChristian Kullmann - CEO & Chairman of the Executive...

5 days ago - Seeking Alpha

Silicone Market worth $33,246.3 Million by 2030, at a CAGR of 5.2%, says MarketsandMarkets™

Delray Beach, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Silicone Market was worth USD 24,502.4 million in 2024 and is projected to reach USD 33,246.3 million by 2030, at a CAGR of 5.2%, as per the rec...

8 days ago - Benzinga

Global Feed Vitamins Market: Growth Outlook, Trends, and Strategic Insights

Delray Beach, FL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The global feed vitamins market is set for steady expansion, reflecting the livestock industry's growing emphasis on balanced, science-based animal ...

22 days ago - Benzinga

SINTX (SINT) Partners with Evonik to Enhance Implant Manufacturing

SINTX (SINT) Partners with Evonik to Enhance Implant Manufacturing

2 months ago - GuruFocus

Evonik Q3 Adj. EBITDA Declines

(RTTNews) - Evonik (EVK.DE) posted a third quarter net loss of 106 million euros compared to net income of 223 million euros, last year. Adjusted net income declined to 128 million euros from 271 mill...

3 months ago - Nasdaq

Silicone Market worth $33,246.3 million by 2030, at a CAGR of 5.2%, says MarketsandMarkets™

Delray Beach, FL, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The Silicone Market was worth USD 24,502.4 million in 2024 and is projected to reach USD 33,246.3 million by 2030, at a CAGR of 5.2%, as per the rec...

4 months ago - Benzinga

Tire Market to Reach USD 462.9 billion by 2032, Growing At An 4.34% CAGR - Credence Research

PUNE, India , Oct. 15, 2025 /PRNewswire/ -- Market Overview The global tire market is experiencing robust expansion, driven by rising vehicle production, infrastructure development, and evolving consu...

4 months ago - Benzinga

Evonik Sees Persistently Weak Demand Until Year-end; Adjusts FY25 Outlook

(RTTNews) - Evonik Industries AG has adjusted the outlook for fiscal 2025. For 2025, Evonik had previously expected adjusted EBITDA to be between 2.0 billion and 2.3 billion euros, with the company mo...

4 months ago - Nasdaq

Evonik Industries reports Q2 results

6 months ago - Seeking Alpha

Evonik Industries AG (EVKIF) Q1 2025 Earnings Call Transcript

Evonik Industries AG (OTCPK:EVKIF) Q1 2025 Results Conference Call May 12, 2025 5:00 AM ETCompany ParticipantsChristian Kullmann - Chairman of the Executive...

9 months ago - Seeking Alpha

Evonik Industries reports Q1 results

9 months ago - Seeking Alpha

Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development

Cayman Islands, December 17, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven can...

1 year ago - Benzinga